Results 111 to 120 of about 3,661 (213)

Effective correction of genitourinary menopausal syndrome by the method of fractional laser ablation [PDF]

open access: yesРМЖ. Мать и дитя, 2018
Effective correction of genitourinary menopausal syndrome by the method of fractional laser ablation Dobrokhotova Yu.E., Ilyina I.Yu., Venediktova M.G., Utina M.S., Morozova K.V., Suvorova V.A., Vasilyeva A.S.
Yu.E. Dobrokhotova   +6 more
doaj  

Effectiveness of nonhormonal products for the treatment of women with vaginal atrophy. [Efectividad de productos no hormonales para el tratamiento de las mujeres con atrofia vaginal]. [PDF]

open access: yes, 2019
Objective: To describe the clinical progress of women with vaginal atrophy who receive nonhormonal treatment. Material and methods: Single-center retrospective longitudinal observational descriptive study in postmenopausal women aged 45-60 years with ...
Cristóbal García, Ignacio   +3 more
core   +1 more source

Post-menopausal vulvovaginal atrophy — an overview of the current treatment options [PDF]

open access: yes, 2018
Sex hormone deficiency in post-menopausal women causes changes in the lower urinary tract. Vulvovaginal atrophy is a pathology resulting from those changes. VVA has a negative effect on the quality of life therefore prompting a search for new therapeutic
Jakiel, Grzegorz   +3 more
core   +2 more sources

Non–invasive vulvovaginal rejuvenation: A review [PDF]

open access: yes
Background: Non–invasive vulvovaginal rejuvenation is a promising option for women who want to restore the appearance and function of the vagina. Vaginal atrophy and vulvovaginal laxity are caused by several circumstances, including ageing, menopause ...
Dhillon, Jesryn, Jusuf, Nelva Karmila
core   +2 more sources

An Overview of Vulvovaginal Atrophy‑Related Sexual Dysfunction in Postmenopausal Women [PDF]

open access: yes, 2015
Menopause and the climacteric period are associated with adverse risk factors for the development of vulvovaginal atrophyrelated sexual dysfunction.
Agu, PU   +3 more
core   +1 more source

The Effect of the CO2 Fractional Laser or Premarin Vaginal Cream on Improving Sexual Function in Menopausal Women: A Randomized Controlled Trial [PDF]

open access: yes, 2020
Introduction:Sexual dysfunction is a complex problem in postmenopausal women with a prevalence rate of 68 - 86 %. This study aimed to evaluate the effect of a fractional CO2 laser or vaginal cream on the improvement of sexual function in menopausal women.
Eftekhar, Tahereh   +4 more
core  

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study

open access: yesMedical Devices: Evidence and Research, 2020
Aino Fianu Jonasson,1 Marie Bixo,2 Inger Sundström Poromaa,3 Mikael Åstrom4 1Department of Clinical Sciences, Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institute, Stockholm, Sweden; 2Department of Clinical ...
Fianu Jonasson A   +3 more
doaj  

Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results [PDF]

open access: yes
Objective: The real-world PatiEnt satisfactiON studY (PEONY) involves postmenopausal women already treated or starting local estrogen therapy (LET) or ospemifene.
Albani F.   +10 more
core   +1 more source

Effect of the Fractional CO2 Laser on the Quality of Life, General Health, and Genitourinary Symptoms in Postmenopausal Women With Vaginal Atrophy: A Prospective Cohort [PDF]

open access: yes, 2020
Introduction: After menopause women experience vaginal atrophy related to hormonal changes and estrogen deficiency. The purpose of this paper was to evaluate the effect of the fractional CO2 laser on the quality of life, vaginal atrophy symptoms, and ...
Adabi, Khadijeh   +4 more
core  

Efficacy and safety of ultra-low-dose Vagifem (10 mcg)

open access: yesPatient Preference and Adherence, 2011
Janet A Chollet1,2 1Beth Israel Deaconess Medical Center, Boston, MA, USA; 2Pear Tree Pharmaceuticals, Waltham, MA, USA Abstract: Vulvovaginal atrophy [VVA] is defined as inflammation of the vaginal epithelium due to atrophy secondary to decreased levels
Chollet JA
doaj  

Home - About - Disclaimer - Privacy